Trials / Withdrawn
WithdrawnNCT02308436
Prophylactic Effect of a CANDIDA Mouthwash, Containing the Curolox™ Peptide
Prophylactic Effect of a CANDIDA Mouthwash, Containing the Curolox™ Peptide: a Mono-centre, Not-controlled. Not Blinded, Not-randmised in Situ Study
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Mibelle AG · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
In vitro results showed a protective effect against acids for the mouthwash containing Curolox™ peptide. The goal of this in situ study is to detect the Curolox™ peptide under natural oral conditions on the tooth surface and to proof the in vitro results obtained. So far there are no effect and safety data of the Curolox™ mouthwash under natural oral conditions available.
Detailed description
The primary objective of the study is the detection of the Curolox™ peptide on the bovine enamel sample (proof-of-concept) under in vivo conditions after rinsing with the peptide-containing mouth wash. Secondary Objectives The secondary objectives of the study are: 1. safety and tolerance of the mouthwash in participants 2. identification of the duration the Curolox™ peptide is present on the bovine tooth surface under in vivo conditions 3. identification of the most effective mouthwash rinsing volume (2.5 mL or 5 mL) 4. prophylactic effect of multiple applications of the mouthwash confirmation of the prophylactic effect of the Curolox™ peptide obtained in in vitro study
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Candida Mouthwash with Curolox™ Peptide | Prophylaxis - protection and care of teeth against caries \& acidic challenges |
Timeline
- Start date
- 2015-02-01
- Primary completion
- 2015-03-01
- Completion
- 2015-03-01
- First posted
- 2014-12-04
- Last updated
- 2015-08-28
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT02308436. Inclusion in this directory is not an endorsement.